Vietnam Pharmaceuticals and Healthcare Report Q2 2010

Executive Summary ....................................................5
SWOT Analysis............................................................6
Vietnam Pharmaceutical And Healthcare Industry SWOT ............................................... 6
Vietnam Political SWOT............... 7
Vietnam Economic SWOT................................................................................................. 8
Vietnam Business Environment SWOT.............................................................................. 9
Vietnam – Business Environment Ratings..............10
Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q210............... 10
Limits Of Potential Returns............................................................................................. 10
Risks To Realisation Of Returns ..................................................................................... 11
Market Summary .......................................................12
Regulatory Regime....................................................14
Pharmaceutical Advertising............................................................................................ 14
Intellectual Property Environment.................................................................................. 15
IP Shortcomings.......................... 15
Counterfeit Drugs ....................... 17
Other Regulatory Issues.............. 17
Pricing And Reimbursement Regime............................................................................... 18
Industry Trends And Developments ........................22
Epidemiology.............................. 22
Healthcare Financing................. 26
Healthcare Insurance ................. 27
Healthcare And Pharmaceutical Reforms....................................................................... 28
Foreign Partnerships.................. 29
Domestic Pharmaceutical Sector.................................................................................... 30
Foreign Pharmaceutical Sector ...................................................................................... 33
Traditional Medicines................. 34
Retail Sector ............................... 35
Table: Key Aspects Of Good Pharmacy Practice (GPP) In Developing Countries.......... 37
Research And Development ............................................................................................ 37
Biotechnology Sector .................. 38
Industry Forecast Scenario .......................................42
Overall Market Forecast................................................................................................. 42
Key Growth Factors – Industry....................................................................................... 44
Macroeconomic Activity ................................................................................................. 46
Vietnam – Economic Activity .......................................................................................... 48
Prescription Drug Market Forecast................................................................................ 49
OTC Medicine Market Forecast ..................................................................................... 51
Patented Product Market Forecast ................................................................................. 53
Generic Drug Market Forecast....................................................................................... 54
Pharmaceutical Trade Forecast ..................................................................................... 55
Medical Device Market Forecast.................................................................................... 57
Other Healthcare Data Forecasts................................................................................... 58
Key Risks To Forecast Scenario........................................................................... 60
Competitive Landscape............................................61
Company Profiles......................................................63
Indigenous Manufacturer Profiles ....................................................................................... 63
Vietnam Pharmaceutical Corporation (Vinapharm)....................................................... 63
Vietnam OPV Pharmaceutical Co................................................................................... 65
Vietnam Pharmaceutical Joint Stock Company (Ampharco) ........................................... 67
Vidipha Central Pharmaceutical Joint Stock Company .................................................. 69
Leading Multinational Manufacturers ................................................................................. 70
Pfizer .......................................... 70
Sanofi-Aventis............................. 71
Novartis ...................................... 73
Merck & Co ................................ 75
Country Snapshot: Vietnam Demographic Data.........................................................................................76
Section 1: Population.................. 76
Table: Demographic Indicators, 2005-2030................................................................... 76
Table: Rural/Urban Breakdown, 2005-2030 .................................................................. 77
Section 2: Education And Healthcare............................................................................. 77
Table: Education, 2002-2005 ......................................................................................... 77
Table: Vital Statistics, 2005-2030................................................................................... 77
Section 3: Labour Market And Spending Power ............................................................. 78
Table: Employment Indicators, 1999-2004..................................................................... 78
Table: Consumer Expenditure, 2000-2012 (US$) ........................................................... 78
Methodology ......................................................79
How We Generate Our Pharmaceutical Industry Forecasts ................................................ 79
Pharmaceutical Business Environment Ratings Methodology ............................................. 80
Ratings Overview........................ 80
Table: Pharmaceutical Business Environment Indicators .............................................. 81
Weighting.................................... 82
Table: Weighting Of Components................................................................................... 82
Sources ............................................ 82
Forecast Tables .........................................................83